Raymond James lowered the firm’s price target on Aquestive Therapeutics (AQST) to $7 from $8 and keeps an Outperform rating on the shares. Aquestive’s Q4 results slightly missed expectations ...

In a report released today, Gary Nachman from Raymond James maintained a Buy rating on Aquestive Therapeutics (AQST – Research Report), with a price target of $7.00. See what stocks are ...

R&B/Hip-Hop Airplay The week’s most popular songs, ranked by radio airplay audience impressions based on monitored airplay compiled by Luminate. Audience totals are derived, in part, using ...

Nate Raymond reports on the federal judiciary and litigation. He can be reached at [email protected]. US judge says Musk's DOGE must release records on operations run in 'secrecy' A ...

R&B/Hip-Hop Airplay The week’s most popular songs, ranked by radio airplay audience impressions based on monitored airplay compiled by Luminate. Audience totals are derived, in part, using ...

Bonus Oct 07, 1996 Oct 31, 1996 Sep 04, 1996 Bonus Ratio: 1 share(s) for every 2 shares held Bonus Jan 29, 1988-Sep 03, 1988 Bonus Ratio: 1 share(s) for every 1 shares held Raymond Ltd., incorporated ...

After hours: March 11 at 6:21:53 PM EDT Loading Chart for RJF ...

Thank you for reporting this station. We will review the data in question. You are about to report this weather station for bad data. Please select the information that is incorrect.